Synopsys analyst price targets moved higher after the company’s fiscal Q2 2026 earnings report, even as SNPS shares fell 8.6% on the session, creating one of the sharper post-earnings divergences in the EDA sector this year. The disconnect reflects a market that looked past the headline beats and focused squarely on how those beats were made.
| Metric | Q2 FY2026 |
|---|---|
| Revenue | $2.28B (+42% YoY) |
| Ansys contribution to revenue | $652.4M |
| Adjusted EPS | $3.35 (est. $3.15) |
| GAAP diluted EPS | $0.09 (vs. $2.24 YoY) |
| Full-year adjusted EPS guidance (midpoint) | $14.76 |
What the GAAP Numbers Actually Show
The adjusted figures looked clean. Below them, the picture was messier. Synopsys’s 8-K filed May 27 shows GAAP net income from continuing operations attributable to the company fell to just $17.1 million, with diluted GAAP EPS of $0.09. That compares to $2.24 a year earlier.
Two line items drove most of that compression: $403.6 million in amortization of acquired intangibles and $115.9 million in restructuring charges, both tied to the Ansys deal. These are non-cash or one-time in nature, which is why management strips them from adjusted results. But the scale is hard to ignore when organic growth ex-Ansys ran at just 3% to 4% for the quarter.
According to the Q2 earnings call transcript, Ansys contributed $652.4 million of the quarter’s revenue. The full-year guidance range of $9.625 billion to $9.705 billion also carries a $60 million accounting impact from Ansys channel revenue and a $40 million expected reduction from a pending processor IP divestiture. Strip those out, and the guidance raise looks thinner.
Synopsys Analyst Price Targets Diverge From Market Action
Synopsys analyst price targets tracked by MarketBeat rose an average of roughly 7% after earnings, with no tracked targets moving lower. The post-earnings average settled near $538, below the broader consensus of $564, which is being held up by older, pre-report figures. At the current price of $475.62, the updated $538 average implies about 13% upside. BNP Paribas Exane carries an Underweight on the stock; Piper Sandler is at Hold.
That analyst optimism sits alongside a stock that has gone essentially nowhere since January 2025. The SEC filings summary puts the 52-week range at $376.18 to $651.73, meaning SNPS is trading closer to its low than its high. The S&P 500 is up more than 25% over the same stretch. The iShares Semiconductor ETF is up more than 150%.
Even Cadence Design Systems, the other dominant EDA player and one without Ansys integration drag, has only matched the S&P 500 over that period. Both stocks are getting left behind in the same semiconductor rally they help enable.
NVIDIA’s Stake and the Monetization Question
NVIDIA invested $2 billion in Synopsys at $414.79 per share last December, establishing a multiyear strategic partnership around agentic AI engineering and cloud access. That per-share entry price is now below current trading levels, but it also explains a chunk of the share count expansion that compressed per-share metrics this quarter. Synopsys’s share count rose roughly 23% year over year.
On the call, management flagged two monetization levers: new pricing structures for intellectual property and consumption-based revenue tied to AI-assisted chip design workflows. Both are early stage. The company expects a handful of signed customer agreements under the new IP model before fiscal year-end, with its fiscal year closing October 31, 2026.
For Q3, the Financial Supplement puts revenue guidance at $2.410 billion to $2.460 billion, with non-GAAP EPS of $3.63 to $3.69. That sequential step-up is meaningful, but the market appears to be holding out for something more structural.
The Investor Day scheduled for late September is shaping up as the cleaner test. That is when Synopsys says it will lay out the full monetization roadmap. Until then, Synopsys analyst price targets will likely stay elevated relative to where shares are trading, and the gap between Wall Street’s models and the market’s verdict stays open.
